Equities Research Analysts’ price target changes for Wednesday, December 24th:
Agios Pharmaceuticals (NASDAQ:AGIO) had its target price raised by Bank of America Corporation from $32.00 to $34.00. Bank of America Corporation currently has a buy rating on the stock.
Agios Pharmaceuticals (NASDAQ:AGIO) had its target price raised by Truist Financial Corporation from $32.00 to $38.00. They currently have a buy rating on the stock.
C.H. Robinson Worldwide (NASDAQ:CHRW) had its target price increased by Bank of America Corporation from $167.00 to $182.00. They currently have a buy rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its target price trimmed by President Capital from $90.00 to $88.00.
DTE Energy (NYSE:DTE) had its target price reduced by BMO Capital Markets from $151.00 to $148.00. They currently have a market perform rating on the stock.
Gemini Space Station (NASDAQ:GEMI) had its price target trimmed by Mizuho from $30.00 to $26.00. The firm currently has an outperform rating on the stock.
Honeywell International (NASDAQ:HON) had its price target cut by Barclays PLC from $269.00 to $250.00. Barclays PLC currently has an overweight rating on the stock.
Huron Consulting Group (NASDAQ:HURN) had its target price increased by Benchmark Co. from $180.00 to $215.00. They currently have a buy rating on the stock.
MakeMyTrip (NASDAQ:MMYT) had its target price reduced by Bank of America Corporation from $115.00 to $113.00. They currently have a buy rating on the stock.
PayPal (NASDAQ:PYPL) had its target price cut by UBS Group AG from $80.00 to $65.00.
Schneider National (NYSE:SNDR) had its price target boosted by Bank of America Corporation from $26.00 to $28.00. Bank of America Corporation currently has a neutral rating on the stock.
WhiteFiber (NASDAQ:WYFI) had its target price trimmed by B. Riley from $44.00 to $40.00. They currently have a buy rating on the stock.
Receive News & Ratings for Agios Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agios Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.
